3,006
Views
61
CrossRef citations to date
0
Altmetric
Reviews

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

, , , &
Pages 1418-1429 | Received 04 Nov 2015, Accepted 20 Dec 2015, Published online: 06 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Xiaojie Chu, Yang Li, Weiwei Huang, Xuejun Feng, Pengyan Sun, Yufeng Yao, Xu Yang, Wenjia Sun, Hongmei Bai, Cunbao Liu & Yanbing Ma. (2018) Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1199-1209.
Read now
Alina Steinbach, Jan Winter, Miriam Reuschenbach, Renata Blatnik, Alexandra Klevenz, Miriam Bertrand, Stephanie Hoppe, Magnus von Knebel Doeberitz, Agnieszka K. Grabowska & Angelika B. Riemer. (2017) ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism. OncoImmunology 6:7.
Read now
Nicolas Çuburu & John T. Schiller. (2016) Moving forward with human papillomavirus immunotherapies. Human Vaccines & Immunotherapeutics 12:11, pages 2875-2880.
Read now

Articles from other publishers (58)

Shulin Li, Sanne Johanna Maria Hoefnagel & Kausilia Krishnawatie Krishnadath. (2023) Single domain Camelid antibody fragments for molecular imaging and therapy of cancer. Frontiers in Oncology 13.
Crossref
Anna Jéssica Duarte Silva, Ingrid Andrêssa de Moura, Marco Antonio Turiah Machado da Gama, Lígia Rosa Sales Leal, Samara Sousa de Pinho, Benigno Cristofer Flores Espinoza, Daffany Luana dos Santos, Vanessa Emanuelle Pereira Santos, Matheus Gardini Amancio Marques De Sena, Maria Da Conceição Viana Invenção, Larissa Silva de Macêdo, Pedro Luiz de França Neto & Antonio Carlos de Freitas. (2023) Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment. Vaccines 11:8, pages 1354.
Crossref
Rehana V. Hewavisenti, Joshua Arena, Chantelle L. Ahlenstiel & Sarah C. Sasson. (2023) Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk. Frontiers in Immunology 14.
Crossref
David Langan, Ruipeng Wang, Keshanti Tidwell, Selome Mitiku, Alison Farrell, Catrina Johnson, Adam Parks, Lauren Suarez, Shweta Jain, Sojung Kim, Kristi Jones, Mathias Oelke & Jerome Zeldis. (2022) AIM™ platform: A new immunotherapy approach for viral diseases. Frontiers in Medicine 9.
Crossref
Chloe S Lalonde, Yong Teng, Barbara A Burtness, Robert L Ferris, Rafi Ahmed & Nabil F Saba. (2022) The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss. JNCI: Journal of the National Cancer Institute 114:10, pages 1333-1337.
Crossref
Anish Nag, Preeti Verma, Subhabrata Paul & Rita Kundu. (2022) In Silico Analysis of the Apoptotic and HPV Inhibitory Roles of Some Selected Phytochemicals Detected from the Rhizomes of Greater Cardamom. Applied Biochemistry and Biotechnology 194:10, pages 4867-4891.
Crossref
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, Tamoghni Mitra, Abhijit Dey, Sumira Malik, Bonglee Kim & Rohit Gundamaraju. (2022) Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs. Frontiers in Oncology 12.
Crossref
Soudabeh Yarmohammadi, Mohtasham Ghaffari, Yadollah Mehrabi, Samira Mousavi & Ali Ramezankhani. (2022) Designing and psychometric assessment of the scale of factors influencing HPV vaccine uptake behaviors in young adults. Infectious Agents and Cancer 17:1.
Crossref
Michael Wotman, Brandon Gold, Mai Takahashi, Lindsey Draper & Marshall Posner. (2022) Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma. Current Otorhinolaryngology Reports 10:2, pages 208-217.
Crossref
Ali Hajiran, Taylor Bracco, Logan Zemp & Philippe E. Spiess. (2022) Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma. Urologic Oncology: Seminars and Original Investigations 40:5, pages 173-178.
Crossref
Ridhima Jasrotia, Daljeet Singh Dhanjal, Sonali Bhardwaj, Parvarish Sharma, Chirag Chopra, Reena Singh, Anupam Kumar, Anamika Mubayi, Deepak Kumar, Raj Kumar & Abhineet Goyal. (2022) Nanotechnology based vaccines: Cervical cancer management and perspectives. Journal of Drug Delivery Science and Technology 71, pages 103351.
Crossref
Steven F. Gameiro, Andris M. Evans & Joe S. Mymryk. (2021) The tumor immune microenvironments of HPV + and HPV − head and neck cancers . WIREs Mechanisms of Disease 14:2.
Crossref
Seyed Amirreza Fatemi, Nadia Seifi, Shiva Rasekh, Sogand Amiri, Seyed Mohammad Iman Moezzi, Ashkan Bagheri, Shirin Fathi & Manica Negahdaripour. 2022. Immunotherapeutics. Immunotherapeutics 51 90 .
Matin Kayyal, Azam Bolhassani, Zahra Noormohammadi & Majid Sadeghizadeh. (2021) Immunological responses and anti-tumor effects of HPV16/18 L1-L2-E7 multiepitope fusion construct along with curcumin and nanocurcumin in C57BL/6 mouse model. Life Sciences 285, pages 119945.
Crossref
Tzy Harn Chua, Lavisha S Punjabi & Li Yan Khor. (2021) Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens 10:11, pages 1410.
Crossref
Aida Ferreiro-Iglesias, James D. McKay, Nicole Brenner, Shama Virani, Corina Lesseur, Valerie Gaborieau, Andy R. Ness, Rayjean J. Hung, Geoffrey Liu, Brenda Diergaarde, Andrew F. Olshan, Neil Hayes, Mark C. Weissler, Lea Schroeder, Noemi Bender, Michael Pawlita, Steve Thomas, Miranda Pring, Tom Dudding, Beatriz Kanterewicz, Robert Ferris, Sera Thomas, Yonathan Brhane, Virginia Díez-Obrero, Maja Milojevic, Karl Smith-Byrne, Daniela Mariosa, Mattias J. Johansson, Rolando Herrero, Stefania Boccia, Gabriella Cadoni, Martin Lacko, Ivana Holcátová, Wolfgang Ahrens, Pagona Lagiou, Areti Lagiou, Jerry Polesel, Lorenzo Simonato, Franco Merletti, Claire M. Healy, Bo T. Hansen, Mari Nygård, David I. Conway, Sylvia Wright, Tatiana V. Macfarlane, Max Robinson, Laia Alemany, Antonio Agudo, Ariana Znaor, Christopher I. Amos, Tim Waterboer & Paul Brennan. (2021) Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nature Communications 12:1.
Crossref
Christiane S. Eberhardt, Haydn T. Kissick, Mihir R. Patel, Maria A. Cardenas, Nataliya Prokhnevska, Rebecca C. Obeng, Tahseen H. Nasti, Christopher C. Griffith, Se Jin Im, Xu Wang, Dong M. Shin, Mary Carrington, Zhuo G. Chen, John Sidney, Alessandro Sette, Nabil F. Saba, Andreas Wieland & Rafi Ahmed. (2021) Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. Nature 597:7875, pages 279-284.
Crossref
Andreas Wieland, Mihir R. Patel, Maria A. Cardenas, Christiane S. Eberhardt, William H. Hudson, Rebecca C. Obeng, Christopher C. Griffith, Xu Wang, Zhuo G. Chen, Haydn T. Kissick, Nabil F. Saba & Rafi Ahmed. (2020) Defining HPV-specific B cell responses in patients with head and neck cancer. Nature 597:7875, pages 274-278.
Crossref
Noor Ayesha, Sara Aboulaghras, Muhammad Jahangeer, Areej Riasat, Rehana Ramzan, Rameen Fatima, Muhammad Akram, Abdelaali Balahbib, Abdelhakim Bouyahya, Ekaterina Sepiashvili, Gokhan Zengin & Mohammad Ali Shariati. (2021) Physiopathology and effectiveness of therapeutic vaccines against human papillomavirus. Environmental Science and Pollution Research 28:35, pages 47752-47772.
Crossref
S. Steck, P. Went, R. Cathomas & D. Kienle. (2021) Profound and durable responses with PD-1 immune checkpoint inhibitors in patients with metastatic penile squamous cell carcinoma. Current Problems in Cancer: Case Reports 3, pages 100045.
Crossref
Mojgan Padash Barmchi, Miranda Thomas, Jayashree V. Thatte, Arushi Vats, Bing Zhang, Ross L. Cagan & Lawrence Banks. (2021) Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6. Scientific Reports 11:1.
Crossref
Abdulrahim Gari. (2021) Human Papilloma Virus, its Vaccine Significance, Side Effects, and Complications. Pharmacophore 12:4, pages 36-40.
Crossref
Yi Yuan, Xushan Cai, Fangrong Shen & Feng Ma. (2021) HPV post-infection microenvironment and cervical cancer. Cancer Letters 497, pages 243-254.
Crossref
Emily Farmer, Max A. Cheng, Chien-Fu Hung & T.-C. Wu. 2021. Viruses and Human Cancer. Viruses and Human Cancer 157 195 .
Andrew W. Woodham, Stad H. Zeigler, Ella L. Zeyang, Stephen C. Kolifrath, Ross W. Cheloha, Mohammad Rashidian, Rodolfo J. Chaparro, Ronald D. Seidel, Scott J. Garforth, Jason L. Dearling, Maia Mesyngier, Phaneendra K. Duddempudi, Alan B. Packard, Steven C. Almo & Hidde L. Ploegh. (2020) In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography. Nature Methods 17:10, pages 1025-1032.
Crossref
Reem Saleh & Eyad Elkord. (2020) Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression. Seminars in Cancer Biology 65, pages 13-27.
Crossref
Heidar Ali Panahi, Azam Bolhassani, Gholamreza Javadi, Zahra Noormohammadi & Elnaz Agi. (2020) Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses. Immunotherapy 12:7, pages 459-479.
Crossref
Aleksander Celewicz, Marta Celewicz, Michał Michalczyk & Rafał Rzepka. (2020) Perspectives in HPV Secondary Screening and Personalized Therapy Basing on Our Understanding of HPV-Related Carcinogenesis Pathways. Mediators of Inflammation 2020, pages 1-7.
Crossref
Carla J. Chibwesha & Jeffrey S. A. Stringer. (2019) Cervical Cancer as a Global Concern. JAMA 322:16, pages 1558.
Crossref
Emad Matanes & Walter H. Gotlieb. (2019) Immunotherapy of gynecological cancers. Best Practice & Research Clinical Obstetrics & Gynaecology 60, pages 97-110.
Crossref
Enguo Ju, Tingting Li, Suzane Ramos da Silva & Shou-Jiang Gao. (2019) Gold Nanocluster-Mediated Efficient Delivery of Cas9 Protein through pH-Induced Assembly-Disassembly for Inactivation of Virus Oncogenes. ACS Applied Materials & Interfaces 11:38, pages 34717-34724.
Crossref
Eiichi Ishida, Jina Lee, Jean S. Campbell, Patrick D. Chakravarty, Yukio Katori, Takenori Ogawa, Lauren Johnson, Anandaroop Mukhopadhyay, William C. Faquin, Derrick T. Lin, Lori J. Wirth, Robert H. Pierce & Sara I. Pai. (2019) Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model. Cancer Immunology, Immunotherapy 68:8, pages 1273-1286.
Crossref
Felicitas Bossler, Karin Hoppe-Seyler & Felix Hoppe-Seyler. (2019) PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells. International Journal of Molecular Sciences 20:9, pages 2188.
Crossref
Diane M. Da Silva, Joseph G. Skeate, Elena Chavez-Juan, Kim P. Lühen, Jiun-Ming Wu, Chia-Mao Wu, W. Martin Kast & KinKai Hwang. (2019) Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease. Vaccine 37:22, pages 2915-2924.
Crossref
Amrita Singh, Georgia Koutsoumpli, Stephanie van de Wall & Toos Daemen. (2018) An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer Immunology, Immunotherapy 68:5, pages 849-859.
Crossref
Laura Martin-Gomez, Anna R. Giuliano, William J. Fulp, Jimmy Caudell, Michelle Echevarria, Bradley Sirak, Martha Abrahamsen, Kimberly A. Isaacs-Soriano, Juan C. Hernandez-Prera, Bruce M. Wenig, Kathryn Vorwald, Caitlin P. McMullen, J. Trad Wadsworth, Robbert J. Slebos & Christine H. Chung. (2019) Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery 145:5, pages 460.
Crossref
Silvia Massa, Francesca Paolini, Carmela Marino, Rosella Franconi & Aldo Venuti. (2019) Bioproduction of a Therapeutic Vaccine Against Human Papillomavirus in Tomato Hairy Root Cultures. Frontiers in Plant Science 10.
Crossref
Madison Canning, Gang Guo, Miao Yu, Calvin Myint, Michael W. Groves, James Kenneth Byrd & Yan Cui. (2019) Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy. Frontiers in Cell and Developmental Biology 7.
Crossref
Vanina Alzogaray, Mariela Urrutia, Paula Berguer, Andrés Rossi, Vanesa Zylberman, Romina Pardo, Hernán R. Bonomi & Fernando A. Goldbaum. (2019) Characterization of folding-sensitive nanobodies as tools to study the expression and quality of protein particle immunogens. Journal of Biotechnology 293, pages 17-23.
Crossref
Funa Yang, Yulin Yin, Peng Li, Xiaojun Zhang, Defeng Chen, Yang Liu, Jian Wang & Lanwei Guo. (2019) Prevalence of human papillomavirus type-18 in head and neck cancer among the Chinese population. Medicine 98:8, pages e14551.
Crossref
Anna Paaso, Anna Jaakola, Stina Syrjänen  & Karolina  Louvanto. (2019) From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity. Acta Cytologica 63:2, pages 148-158.
Crossref
Istvan Toth, Mattaka Khongkow, Tzu-yu Liu, Stacey Bartlett, Waleed M Hussein, Reshma Nevagi, Zhogfan Jia, Michael J Monteiro, James Wells, Uracha Rungsardthong Ruktanonchai & Mariusz Skwarczynski. (2018) Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer. Precision Nanomedicine 1:3, pages 183-193.
Crossref
Zheng Hu & Ding Ma. (2018) The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Medicine 7:10, pages 5217-5236.
Crossref
Andrew W. Woodham, Ross W. Cheloha, Jingjing Ling, Mohammad Rashidian, Stephen C. Kolifrath, Maia Mesyngier, Joao N. Duarte, Justin M. Bader, Joseph G. Skeate, Diane M. Da Silva, W. Martin Kast & Hidde L. Ploegh. (2018) Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunology Research 6:7, pages 870-880.
Crossref
Aleyo Chabeda, Romana J.R. Yanez, Renate Lamprecht, Ann E. Meyers, Edward P. Rybicki & Inga I. Hitzeroth. (2018) Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Research 5, pages 46-58.
Crossref
Jorge L Cervantes & Amy Hoanganh Doan. (2018) Discrepancies in the evaluation of the safety of the human papillomavirus vaccine. Memórias do Instituto Oswaldo Cruz 113:8.
Crossref
Karin Hoppe-Seyler, Felicitas Bossler, Julia A. Braun, Anja L. Herrmann & Felix Hoppe-Seyler. (2018) The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends in Microbiology 26:2, pages 158-168.
Crossref
Theresa L. Whiteside. (2018) Head and Neck Carcinoma Immunotherapy: Facts and Hopes. Clinical Cancer Research 24:1, pages 6-13.
Crossref
Samuel Alizon, Carmen Murall & Ignacio Bravo. (2017) Why Human Papillomavirus Acute Infections Matter. Viruses 9:10, pages 293.
Crossref
Matthew J. Atherton, Kyle B. Stephenson, Jonathan Pol, Fuan Wang, Charles Lefebvre, David F. Stojdl, Jake K. Nikota, Anna Dvorkin-Gheva, Andrew Nguyen, Lan Chen, Stephanie Johnson-Obaseki, Patrick J. Villeneuve, Jean-Simon Diallo, Jim Dimitroulakos, Yonghong Wan & Brian D. Lichty. (2017) Customized Viral Immunotherapy for HPV-Associated Cancer. Cancer Immunology Research 5:10, pages 847-859.
Crossref
Joongho Joh, Paula M. Chilton, Sarah A. Wilcher, Maryam Zahin, Jino Park, Mary L. Proctor, Shin-je Ghim & Alfred B. Jenson. (2017) T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1. Experimental and Molecular Pathology 103:2, pages 181-190.
Crossref
Hyoung Jin Kim & Hong-Jin Kim. (2017) Current status and future prospects for human papillomavirus vaccines. Archives of Pharmacal Research 40:9, pages 1050-1063.
Crossref
Karin Hoppe-Seyler, Julia Mändl, Svenja Adrian, Bianca Kuhn & Felix Hoppe-Seyler. (2017) Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells. Viruses 9:7, pages 174.
Crossref
Karin Hoppe-SeylerFelicitas BosslerClaudia LohreyJulia BulkescherFrank RöslLars JansenArnulf Mayer, Peter Vaupel, Matthias DürstFelix Hoppe-Seyler. (2017) Induction of dormancy in hypoxic human papillomavirus-positive cancer cells. Proceedings of the National Academy of Sciences 114:6.
Crossref
Sophie Outh-Gauer, Christophe Le Tourneau, Chloé Broudin, Florian Scotte, Hélène Roussel, Stéphane Hans, Marion Mandavit, Eric Tartour & Cécile Badoual. (2017) Actualités sur l’immunothérapie en pathologie des voies aérodigestives supérieures. Annales de Pathologie 37:1, pages 79-89.
Crossref
Inge M. C. M. de Kok & Suzette M. Matthijsse. (2016) HPV-vaccinatie. Bijblijven 33:1, pages 29-40.
Crossref
Soumaya Karaki, Marie Anson, Thi Tran, Delphine Giusti, Charlotte Blanc, Stephane Oudard & Eric Tartour. (2016) Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors. Vaccines 4:4, pages 37.
Crossref
Soumaya Karaki, Helene Pere, Cecile Badoual & Eric Tartour. (2016) Hope in the Long Road Toward the Development of a Therapeutic Human Papillomavirus Vaccine. Clinical Cancer Research 22:10, pages 2317-2319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.